PA
RGNX icon

Profund Advisors’s Regenxbio RGNX Stock Holding History

Profund Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Sell
27,486
-5,559
-17% -$46.1K 0.01% 747
2026
Q1 		$277K Buy
33,045
+10,794
+49% +$113K 0.01% 798
2025
Q4 		$320K Buy
22,251
+7,807
+54% +$97.3K 0.01% 821
2025
Q3 		$139K Buy
14,444
+1,523
+12% +$13.5K ﹤0.01% 1017
2025
Q2 		$106K Buy
+12,921
New +$108K ﹤0.01% 960
2025
Q1 		– Sell
-18,256
Closed -$141K – 1086
2024
Q4 		$141K Buy
18,256
+1,398
+8% +$13.1K 0.01% 1051
2024
Q3 		$177K Sell
16,858
-3,749
-18% -$45.7K 0.01% 1069
2024
Q2 		$241K Sell
20,607
-8,893
-30% -$138K 0.01% 858
2024
Q1 		$622K Buy
29,500
+7,850
+36% +$140K 0.02% 502
2023
Q4 		$389K Sell
21,650
-2,277
-10% -$40.1K 0.02% 647
2023
Q3 		$394K Sell
23,927
-6,244
-21% -$113K 0.02% 537
2023
Q2 		$603K Buy
30,171
+4,452
+17% +$85.8K 0.03% 453
2023
Q1 		$486K Buy
+25,719
New +$569K 0.03% 512
2018
Q4 		– Sell
-5,408
Closed -$408K – 1357
2018
Q3 		$408K Sell
5,408
-478
-8% -$34.4K 0.02% 962
2018
Q2 		$422K Buy
+5,886
New +$281K 0.02% 909

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Profund Advisors's RGNX Position: Q2 2026 in Review

Profund Advisors reduced its Regenxbio (RGNX) stake by 17% in Q2 2026, selling an estimated $46.1K and leaving 27,486 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #747.

Profund Advisors first reported a position in RGNX in Q2 2018 and has held it in 15 quarters since. The position peaked at $622K in Q1 2024. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Profund Advisors held 27,486 shares of Regenxbio worth $329K as of Q2 2026.
  • Profund Advisors sold 5,559 Regenxbio shares in Q2 2026, an estimated $46.1K.
  • Regenxbio made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #747 holding.
  • Profund Advisors first reported a position in Regenxbio in Q2 2018 and has held it in 15 quarters since.
  • Profund Advisors's Regenxbio position peaked at $622K in Q1 2024.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.